NO970553L - Östradiolinneholdende transdermale terapeutiske systemer omfattende hydrofile tilsetningsstoffer - Google Patents

Östradiolinneholdende transdermale terapeutiske systemer omfattende hydrofile tilsetningsstoffer

Info

Publication number
NO970553L
NO970553L NO970553A NO970553A NO970553L NO 970553 L NO970553 L NO 970553L NO 970553 A NO970553 A NO 970553A NO 970553 A NO970553 A NO 970553A NO 970553 L NO970553 L NO 970553L
Authority
NO
Norway
Prior art keywords
water
transdermal therapeutic
therapeutic system
estradiol
matrix
Prior art date
Application number
NO970553A
Other languages
English (en)
Norwegian (no)
Other versions
NO970553D0 (no
Inventor
Michael Horstmann
Walter Mueller
Hanshermann Franke
Thomas Pontzen
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO970553D0 publication Critical patent/NO970553D0/no
Publication of NO970553L publication Critical patent/NO970553L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Auxiliary Drives, Propulsion Controls, And Safety Devices (AREA)
  • Traffic Control Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO970553A 1994-08-20 1997-02-06 Östradiolinneholdende transdermale terapeutiske systemer omfattende hydrofile tilsetningsstoffer NO970553L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4429664A DE4429664C2 (de) 1994-08-20 1994-08-20 Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
PCT/EP1995/003202 WO1996005815A1 (fr) 1994-08-20 1995-08-12 Systeme therapeutique transdermique contenant de l'×stradiol et des additifs hydrophiles

Publications (2)

Publication Number Publication Date
NO970553D0 NO970553D0 (no) 1997-02-06
NO970553L true NO970553L (no) 1997-02-06

Family

ID=6526229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970553A NO970553L (no) 1994-08-20 1997-02-06 Östradiolinneholdende transdermale terapeutiske systemer omfattende hydrofile tilsetningsstoffer

Country Status (21)

Country Link
EP (1) EP0776197B1 (fr)
JP (1) JPH10504314A (fr)
KR (1) KR100374476B1 (fr)
CN (1) CN1073413C (fr)
AT (1) ATE173163T1 (fr)
AU (1) AU700119B2 (fr)
CA (1) CA2197865C (fr)
CZ (1) CZ50897A3 (fr)
DE (2) DE4429664C2 (fr)
DK (1) DK0776197T3 (fr)
ES (1) ES2126308T3 (fr)
FI (1) FI118721B (fr)
HU (1) HUT77093A (fr)
IL (1) IL114948A (fr)
NO (1) NO970553L (fr)
NZ (1) NZ291449A (fr)
PL (1) PL180943B1 (fr)
SI (1) SI0776197T1 (fr)
SK (1) SK280299B6 (fr)
WO (1) WO1996005815A1 (fr)
ZA (1) ZA956926B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623763B2 (en) 1996-01-08 2003-09-23 Lts Lohmann Therape-System Ag Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
DE4223360C1 (fr) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4237453C1 (fr) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut

Also Published As

Publication number Publication date
WO1996005815A1 (fr) 1996-02-29
NO970553D0 (no) 1997-02-06
DK0776197T3 (da) 1999-07-26
KR970705380A (ko) 1997-10-09
EP0776197A1 (fr) 1997-06-04
IL114948A (en) 2000-10-31
CZ50897A3 (en) 1997-06-11
DE4429664A1 (de) 1996-02-22
ATE173163T1 (de) 1998-11-15
KR100374476B1 (ko) 2003-04-23
CA2197865A1 (fr) 1996-02-29
DE59504233D1 (de) 1998-12-17
NZ291449A (en) 1998-09-24
CA2197865C (fr) 2005-10-25
MX9701301A (es) 1998-05-31
CN1155836A (zh) 1997-07-30
EP0776197B1 (fr) 1998-11-11
ES2126308T3 (es) 1999-03-16
FI970702A0 (fi) 1997-02-19
FI970702L (fi) 1997-02-19
FI118721B (fi) 2008-02-29
AU700119B2 (en) 1998-12-24
PL319014A1 (en) 1997-07-21
DE4429664C2 (de) 1997-09-11
SK280299B6 (sk) 1999-11-08
AU3258395A (en) 1996-03-14
JPH10504314A (ja) 1998-04-28
SK21997A3 (en) 1997-07-09
SI0776197T1 (en) 1999-04-30
IL114948A0 (en) 1995-12-08
HUT77093A (hu) 1998-03-02
ZA956926B (en) 1996-03-25
CN1073413C (zh) 2001-10-24
PL180943B1 (pl) 2001-05-31

Similar Documents

Publication Publication Date Title
CA2326662C (fr) Systeme therapeutique pouvant etre active par l'humidite
JPH10505342A (ja) 加水分解に対する保護を備えた経皮性治療システム
US5997897A (en) Process for the production of a transdermal therapeutic system comprising the active substance 17-β-estradiol (anhydrous)
NO970553L (no) Östradiolinneholdende transdermale terapeutiske systemer omfattende hydrofile tilsetningsstoffer
US6537571B1 (en) Transdermal therapeutic system containing the active substance scopolamine base
US5902602A (en) Estradiol-TTS having water-binding additives
MXPA97001301A (en) Transdermal therapeutic system containing estradiol comprising additives higrofili
US5827245A (en) Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous)
HK1032194B (en) Transdermal therapeutic system containing the active substance scopolamine base

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application